Skip to main content
. 2020 Aug 26;20(5):18. doi: 10.3892/etm.2020.9145

Figure 2.

Figure 2

rAd-p53 and/or curcumin synergistically reduces epithelial-mesenchymal transition. (A) The effect of rAd-p53 and/or curcumin on HepG2 cell wound closure following 24, 48 and 72 h rAd-p53 and/or curcumin treatment. Magnification, x100. (B) Expression of N-cadherin, Snail and Twist in HepG2 cells following 24, 48 and 72 h rAd-p53 and/or curcumin treatment. Data are represented as the mean ± standard deviation (n =3). **P<0.01 vs. Con, ##P<0.01 vs. Cur. Cur, curcumin; rAd-p53, recombinant human adenovirus-p53; Con, control.